术中临床测试高估丘脑底核永久DBS电极的治疗窗
本研究纳入59例接受双侧丘脑底核脑深部电刺激(STN DBS)的帕金森病(PD)患者,在手术中及术后程控时于匹配刺激深度下进行逐步递增的单极刺激,比较测试刺激与永久电极的疗效及副作用阈值。术后永久电极在显著更低阈值下引起副作用(P < 0.001),而充分疗效需显著更高阈值(P < 0.001)。结论认为术中测试可能高估治疗窗,永久刺激的疗效与副作用无法由术中测试预测。
要点
- 术后永久电极引起副作用的阈值显著低于术中测试预测值(P < 0.001)。
- 术后永久电极达到充分疗效的阈值显著高于术中测试预测值(P < 0.001)。
- 术中测试可能高估治疗窗,永久刺激的疗效与副作用无法由术中测试预测。
核心结论
- 术中测试可能导致对治疗窗的高估。
- 两种不同电极在STN及周围组织中产生不同的电场扩散,导致不同的激活组织体积(VTA)。
- 参与DBS手术和程控的临床医生应意识到两种刺激设置在电极几何形状、刺激模式以及时间影响方面的差异。
- 永久刺激的疗效与副作用无法由术中测试预测,测试刺激或可作为极低副作用阈值的定向测试。
研究设计与样本
- 研究纳入59例接受双侧STN DBS的PD患者,在手术中及DBS程控时于匹配刺激深度下进行逐步递增的单极刺激临床检查。
- 疗效与副作用阈值通过标准化检查方案获取。
主要发现
- 术后经永久电极刺激引起副作用的阈值显著低于术中测试刺激预测的阈值(P < 0.001)。
- 术后经永久电极刺激达到充分疗效的阈值显著高于术中测试刺激预测的阈值(P < 0.001)。
临床怎么用
- 参与DBS手术和程控的临床医生应意识到两种刺激设置在电极几何形状、刺激模式以及时间影响方面的差异。
- 永久刺激的疗效与副作用无法由术中测试预测。
- 测试刺激或可作为极低副作用阈值的定向测试。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative test stimulation is established to optimize target localization in STN DBS, but requires a time-consuming awake surgery in off-medication state. The aim of this study was to compare the thresholds of stimulation-induced effects of test stimulation and the permanent electrode. METHODS: Fifty-nine PD patients receiving bilateral STN DBS were clinically examined with stepwise increasing monopolar stimulation during surgery and DBS programming at matched stimulation depths. Thresholds of therapeutic and side effects were obtained from standardized examination protocols. RESULTS: Postoperative stimulation via the permanent electrode caused side effects at a significantly lower threshold than predicted during intraoperative test stimulation (P < 0.001); whereas sufficient therapeutic effects were achieved at significantly higher thresholds (P < 0.001). CONCLUSIONS: Intraoperative testing may lead to an overestimation of the therapeutic window. The two different electrodes lead to distinct spreading of the electric field in the STN and surrounding tissues that causes different volume of tissue activated (VTA). Clinicians involved in DBS surgery and programming should be aware of the differences in both stimulation settings, concerning electrodes geometry, stimulation modes as well as the impact of time. Therapeutic and side effects of permanent stimulation are not predictable by intraoperative test stimulation. Test stimulation may be an orientating test for very low thresholds of side effects instead.
引用
- Blume J, Schlaier J, Rothenfußer E, et al. Intraoperative clinical testing overestimates the therapeutic window of the permanent DBS electrode in the subthalamic nucleus. Acta Neurochir (Wien). 2017. PMID: 28699067. doi:10.1007/s00701-017-3255-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。